デフォルト表紙
市場調査レポート
商品コード
1619279

メラトニンの市場規模、シェア、成長分析、製品タイプ別、治療タイプ別、性質別、地域別- 産業予測、2024~2031年

Melatonin Market Size, Share, Growth Analysis, By Product Type (Powder/Tablets, Liquid), By Treatment Type (Dietary Supplements, Pharmaceuticals), By Nature, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 260 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
メラトニンの市場規模、シェア、成長分析、製品タイプ別、治療タイプ別、性質別、地域別- 産業予測、2024~2031年
出版日: 2024年12月20日
発行: SkyQuest
ページ情報: 英文 260 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

メラトニンの世界市場規模は、2022年に4億2,350万米ドルと評価され、2023年の4億6,585万米ドルから2031年には9億9,859万米ドルに成長し、予測期間(2024~2031年)のCAGRは10.0%で成長する見通しです。

メラトニン市場は、睡眠障害の有病率の増加と睡眠の健康に対する消費者の意識の高まりによって、堅調な成長が見込まれています。メラトニンは、概日リズムを調整する松果体によって産生されるホルモンで、主にカプセル、グミ、液体など、サプリメント用の様々な形態で合成されます。不眠症や時差ぼけに対応するだけでなく、抗酸化作用もあるため、飲食品や医薬品、栄養補助食品にも応用されています。2020年、米国におけるメラトニンの売上高は8億2,100万米ドルを超え、近年2倍以上に増加しており、需要の大幅な急増を反映しています。この動向は、睡眠補助食品に対する消費者の関心が高まり続けていることから、メラトニン製品の今後の市場ポテンシャルが高いことを示しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2023年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術の進歩
  • 規制情勢
  • ケーススタディ
  • 顧客と購買基準の分析
  • 貿易分析
  • 原材料の分析

メラトニンの市場規模:製品タイプ別& CAGR(2024-2031)

  • 市場概要
  • 粉末/錠剤
  • 液体

メラトニンの市場規模:治療タイプ別& CAGR(2024-2031)

  • 市場概要
  • 栄養補助食品
  • 医薬品

メラトニンの市場規模:性質別& CAGR(2024-2031)

  • 市場概要
  • 天然
  • 合成

メラトニンの市場規模:地域別& CAGR(2024-2031)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2021-2023)

主要企業プロファイル

  • Pharmavite
  • Jameison
  • Rexall Sundown, Inc.
  • Biotics Research Corporation
  • Pfizer Inc.
  • Solgar Inc.
  • GNC
  • Xiu Zheng
  • Church & Dwight Co., Inc.
  • By-Health
  • Aurobindo Pharma
  • Aspen Holdings
  • B Joshi Agrochem Pharma
  • Amway Corporation
  • Neurim Pharmaceuticals
  • Vitafusion(Church & Dwight brand)
  • Zenith Nutrition

結論と推奨事項

目次
Product Code: SQMIG35I2260

Global Melatonin Market size was valued at USD 423.5 million in 2022 and is poised to grow from USD 465.85 million in 2023 to USD 998.59 million by 2031, growing at a CAGR of 10.0% during the forecast period (2024-2031).

The melatonin market is poised for robust growth, driven by the increasing prevalence of sleep disorders and heightened consumer awareness of sleep health. Melatonin, a hormone produced by the pineal gland that regulates circadian rhythms, is primarily synthesized in various forms for supplementation, including capsules, gummies, and liquids. This versatile product not only addresses insomnia and jet lag but also boasts antioxidant properties, leading to its incorporation in food and beverages, as well as pharmaceutical and dietary applications. In 2020, melatonin sales in the U.S. exceeded $821 million, more than doubling in recent years, reflecting a significant surge in demand. This trend indicates strong market potential for melatonin products in the coming years, as consumer interest in sleep aids continues to rise.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Melatonin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Melatonin Market Segmental Analysis

Global Melatonin Market is segmented by product type, treatment type, nature and region. Based on product type, the market is segmented into powder/tablets and liquid. Based on treatment type, the market is segmented into dietary supplements and pharmaceuticals. Based on nature, the market is segmented into natural and synthetic. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Melatonin Market

The global melatonin market is primarily driven by the rise in disposable income and the expanding workforce resulting from industrialization and globalization. As more individuals pursue demanding careers, instances of insomnia have surged due to unhealthy lifestyles and dietary habits, particularly increased sodium consumption. This can subsequently lead to elevated blood pressure and insomnia symptoms. Consequently, the demand for melatonin supplements has grown as people seek solutions for stress relief and improving sleep quality. During the analysis period, these trends are expected to significantly propel the global melatonin market as individuals prioritize their health and wellbeing.

Restraints in the Global Melatonin Market

The growth of the global melatonin market is significantly hindered by stringent regulations and guidelines surrounding the sale and allowable concentrations of melatonin supplements. These restrictions necessitate prescriptions in many regions, limiting accessibility for consumers and potentially stifling market expansion during the analysis period. As regulatory bodies impose tight controls on dosage and distribution, manufacturers may face challenges in reaching broader audiences, ultimately affecting their ability to innovate and promote their products. Consequently, these regulatory hurdles are key factors that could impede the overall growth trajectory of the melatonin market in the foreseeable future.

Market Trends of the Global Melatonin Market

The Global Melatonin Market is witnessing significant growth driven by its diverse applications, including its burgeoning role in the production of bio-based spray polyurethane foam (SPF). This eco-friendly material is increasingly utilized in construction for insulation and protection, aligning with the growing demand for sustainable building solutions. Additionally, the rising awareness of sleep disorders and the shift towards natural sleep aids are further propelling melatonin's popularity. Coupled with innovations in formulation and increasing consumer preference for organic products, these trends are set to boost the melatonin market significantly in the coming years, highlighting its versatility and sustainability.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies
  • Customer & Buying Criteria Analysis
  • Trade Analysis
  • Raw Material Analysis

Global Melatonin Market Size by Product Type & CAGR (2024-2031)

  • Market Overview
  • Powder/Tablets
  • Liquid

Global Melatonin Market Size by Treatment Type & CAGR (2024-2031)

  • Market Overview
  • Dietary Supplements
  • Pharmaceuticals

Global Melatonin Market Size by Nature & CAGR (2024-2031)

  • Market Overview
  • Natural
  • Synthetic

Global Melatonin Market Size & CAGR (2024-2031)

  • North America (Product Type, Treatment Type, Nature)
    • USA
    • Canada
  • Europe (Product Type, Treatment Type, Nature)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Treatment Type, Nature)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Treatment Type, Nature)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Treatment Type, Nature)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Pharmavite
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jameison
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rexall Sundown, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotics Research Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Solgar Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GNC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Xiu Zheng
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Church & Dwight Co., Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • By-Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aurobindo Pharma
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aspen Holdings
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B Joshi Agrochem Pharma
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amway Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neurim Pharmaceuticals
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitafusion (Church & Dwight brand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zenith Nutrition
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations